The	the	O	O
use	use	O	O
of	of	O	O
serum	serum	O	O
cholinesterase	cholinesterase	O	O
in	in	O	O
succinylcholine	succinylcholine	S_chemical	O
apnoea	apnoea	O	S_disease
.	.	O	O

Fifteen	fifteen	O	O
patients	patients	O	O
demonstrating	demonstrating	O	O
unexpected	unexpected	O	O
prolonged	prolonged	O	O
apnoea	apnoea	O	S_disease
lasting	lasting	O	O
several	several	O	O
hours	hours	O	O
after	after	O	O
succinylcholine	succinylcholine	S_chemical	O
have	have	O	O
been	been	O	O
treated	treated	O	O
by	by	O	O
a	a	O	O
new	new	O	O
preparation	preparation	O	O
of	of	O	O
human	human	O	O
serum	serum	O	O
cholinesterase	cholinesterase	O	O
.	.	O	O

Adequate	adequate	O	O
spontaneous	spontaneous	O	O
respiration	respiration	O	O
was	was	O	O
re-established	re-established	O	O
in	in	O	O
an	an	O	O
average	average	O	O
period	period	O	O
of	of	O	O
ten	ten	O	O
minutes	minutes	O	O
after	after	O	O
the	the	O	O
injection	injection	O	O
.	.	O	O

In	in	O	O
12	12	O	O
patients	patients	O	O
biochemical	biochemical	O	O
genetic	genetic	O	O
examinations	examinations	O	O
confirmed	confirmed	O	O
the	the	O	O
presence	presence	O	O
of	of	O	O
an	an	O	O
atypical	atypical	O	O
serum	serum	O	O
cholinesterase	cholinesterase	O	O
.	.	O	O

In	in	O	O
three	three	O	O
patients	patients	O	O
none	none	O	O
of	of	O	O
the	the	O	O
usual	usual	O	O
variants	variants	O	O
were	were	O	O
found	found	O	O
.	.	O	O

It	it	O	O
is	is	O	O
therefore	therefore	O	O
supposed	supposed	O	O
that	that	O	O
other	other	O	O
unknown	unknown	O	O
variants	variants	O	O
of	of	O	O
serum	serum	O	O
cholinesterase	cholinesterase	O	O
exist	exist	O	O
which	which	O	O
can	can	O	O
not	not	O	O
hydrolyze	hydrolyze	O	O
succinylcholine	succinylcholine	S_chemical	O
.	.	O	O

The	the	O	O
use	use	O	O
of	of	O	O
serum	serum	O	O
cholinesterase	cholinesterase	O	O
in	in	O	O
succinylcholine	succinylcholine	S_chemical	O
apnoea	apnoea	O	S_disease
provided	provided	O	O
considerable	considerable	O	O
relief	relief	O	O
to	to	O	O
both	both	O	O
patient	patient	O	O
and	and	O	O
anaesthetist	anaesthetist	O	O
.	.	O	O

